Long-Term Cost Effectiveness of Early and Sustained Dual Oral Antiplatelet Therapy With Clopidogrel Given for Up to One Year After Percutaneous Coronary Intervention: Results From the Clopidogrel for the Reduction of Events During Observation (CREDO) Trial
S.C. Beinart, P. Kolm, E. VeledarVolume:
14
Year:
2005
Language:
english
DOI:
10.1016/j.accreview.2005.11.046
File:
PDF, 37 KB
english, 2005